Effects of potassium supplements on glucose metabolism in African Americans with prediabetes: a pilot trial

被引:15
作者
Chatterjee, Ranee [1 ]
Slentz, Cris [1 ,3 ]
Davenport, Clemontina A. [2 ]
Johnson, Johanna [1 ,3 ]
Lin, Pao-Hwa [1 ]
Muehlbauer, Michael [1 ,3 ]
D'Alessio, David [1 ,3 ]
Svetkey, Laura P. [1 ]
Edelman, David [1 ]
机构
[1] Duke Univ, Dept Med, Durham, NC 27708 USA
[2] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA
[3] Duke Univ, Duke Mol Physiol Inst, Durham, NC USA
关键词
potassium chloride; potassium; risk factor; glucose metabolism; prediabetes; African Americans; TYPE-2; DIABETES-MELLITUS; SERUM POTASSIUM; INSULIN SENSITIVITY; THIAZIDE DIURETICS; INTOLERANCE; TOLERANCE; RISK; HYPERTENSION; ALDOSTERONE; HYPOKALEMIA;
D O I
10.3945/ajcn.117.161570
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Low potassium has been identified both as a risk factor for type 2 diabetes and as a mediator of the racial disparity in diabetes risk. Low potassium could be a potentially modifiable risk factor, particularly for African Americans. Objective: We sought to determine the effects of potassium chloride (KCl) supplements, at a commonly prescribed dose, on measures of potassium and glucose metabolism. Design: Among African-American adults with prediabetes, we conducted a double-blinded pilot randomized controlled trial that compared the effects of 40 mEq K/d as KCl supplements with a matching placebo, taken for 3 mo, on measures of potassium and glucose metabolism, with measures collected from frequently sampled oral-glucose-tolerance tests (OGTTs). Results: Twenty-seven of 29 recruited participants completed the trial. Participants had high adherence to the study medication (92% by pill count). Participants in both groups gained weight, with an overall mean +/- SD weight gain of 1.24 +/- 2.03 kg. In comparison with participants who received placebo, urine potassium but not serum potassium increased significantly among participants randomly assigned to receive KCl (P = 0.005 and 0.258, respectively). At the end of the study, participants taking KCl had stable or improved fasting glucose, with a mean 6 SD change in fasting glucose of -1.16 8.4 mg/dL compared with an increase of 6.1 +/- 7.6 mg/dL in those who received placebo (P = 0.03 for comparison between arms). There were no significant differences in glucose or insulin measures during the OGTT between the 2 groups, but there was a trend for improved insulin sensitivity in potassium-treated participants. Conclusions: In this pilot trial, KCl at a dose of 40 mEq/d did not increase serum potassium significantly. However, despite weight gain, KCl prevented worsening of fasting glucose. Further studies in larger sample sizes, as well as with interventions to increase serum potassium more than was achieved with our intervention, are indicated to definitively test this potentially safe and inexpensive approach to reducing diabetes risk.
引用
收藏
页码:1431 / 1438
页数:8
相关论文
共 29 条
[1]   Thiazide-Induced Dysglycemia Call for Research From a Working Group From the National Heart, Lung, and Blood Institute [J].
Carter, Barry L. ;
Einhorn, Paula T. ;
Brands, Michael ;
He, Jiang ;
Cutler, Jeffrey A. ;
Whelton, Paul K. ;
Bakris, George L. ;
Brancati, Frederick L. ;
Cushman, William C. ;
Oparil, Suzanne ;
Wright, Jackson T., Jr. .
HYPERTENSION, 2008, 52 (01) :30-36
[2]   Potassium intake and risk of incident type 2 diabetes mellitus: the Coronary Artery Risk Development in Young Adults (CARDIA) Study [J].
Chatterjee, R. ;
Colangelo, L. A. ;
Yeh, H. C. ;
Anderson, C. A. ;
Daviglus, M. L. ;
Liu, K. ;
Brancati, F. L. .
DIABETOLOGIA, 2012, 55 (05) :1295-1303
[3]   Serum potassium is a predictor of incident diabetes in African Americans with normal aldosterone: the Jackson Heart Study [J].
Chatterjee, Ranee ;
Davenport, Clemontina A. ;
Svetkey, Laura P. ;
Batch, Bryan C. ;
Lin, Pao-Hwa ;
Ramachandran, Vasan S. ;
Fox, Ervin R. ;
Harman, Jane ;
Yeh, Hsin-Chieh ;
Selvin, Elizabeth ;
Correa, Adolfo ;
Butler, Kenneth ;
Edelman, David .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2017, 105 (02) :442-449
[4]   Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study [J].
Chatterjee, Ranee ;
Yeh, Hsin-Chieh ;
Shafi, Tariq ;
Anderson, Cheryl ;
Pankow, James S. ;
Miller, Edgar R. ;
Levine, David ;
Selvin, Elizabeth ;
Brancati, Frederick L. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 93 (05) :1087-1091
[5]   Serum and Dietary Potassium and Risk of Incident Type 2 Diabetes Mellitus The Atherosclerosis Risk in Communities (ARIC) Study [J].
Chatterjee, Ranee ;
Yeh, Hsin-Chieh ;
Shafi, Tariq ;
Selvin, Elizabeth ;
Anderson, Cheryl ;
Pankow, James S. ;
Miller, Edgar ;
Brancati, Frederick .
ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (19) :1745-1751
[6]  
CHOWDHURY F R, 1970, Hormone and Metabolic Research, V2, P13
[7]   Effects of potassium citrate or potassium chloride in patients with combined glucose intolerance: A placebo-controlled pilot study [J].
Conen, Katrin ;
Scanni, Roberto ;
Gombert, Marie-Therese ;
Hulter, Henry N. ;
Krapf, Reto .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (06) :1158-1161
[8]   HYPERTENSION POTASSIUM ION AND IMPAIRED CARBOHYDRATE TOLERANCE [J].
CONN, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1965, 273 (21) :1135-&
[9]   Full Accounting of Diabetes and Pre-Diabetes in the US Population in 1988-1994 and 2005-2006 [J].
Cowie, Catherine C. ;
Rust, Keith F. ;
Ford, Earl. S. ;
Eberhardt, Mark S. ;
Byrd-Holt, Danita D. ;
Li, Chaoyang ;
Williams, Desmond E. ;
Gregg, Edward W. ;
Bainbridge, Kathleen E. ;
Saydah, Sharon H. ;
Geiss, Linda S. .
DIABETES CARE, 2009, 32 (02) :287-294
[10]   Serum potassium is an age-dependent risk factor for pre-diabetes and diabetes in the Israeli population [J].
Doenyas-Barak, Keren ;
Beberashvili, Ilia ;
Vinker, Shlomo .
DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (02) :103-109